Proteoshape Diagnostics
Corporation
Proteoshape Diagnostics
Corporation

Accelerating Diagnostics of Neurodegenerative Diseases and Cancer

Accelerating Diagnostics of Neurodegenerative Diseases and CancerAccelerating Diagnostics of Neurodegenerative Diseases and CancerAccelerating Diagnostics of Neurodegenerative Diseases and CancerAccelerating Diagnostics of Neurodegenerative Diseases and Cancer

Transformative diagnostics for the early detection of Alzheimer's disease and for cancer treatment.

Contact Us

Accelerating Diagnostics of Neurodegenerative Diseases and Cancer

Accelerating Diagnostics of Neurodegenerative Diseases and CancerAccelerating Diagnostics of Neurodegenerative Diseases and CancerAccelerating Diagnostics of Neurodegenerative Diseases and CancerAccelerating Diagnostics of Neurodegenerative Diseases and Cancer

Transformative diagnostics for the early detection of Alzheimer's disease and for cancer treatment.

Contact Us

3D proteomics for the benefit of patients.

Why Proteoshape Diagnostics

Proteoshape Diagnostics Makes a Difference

How Proteoshape Diagnostics Helps

Misfolded proteins are the basis for age related neurodegeneration and cardiovascular deterioration. Proteoshape Diagnostics develops diagnostic assays for early detection of disease.

How Proteoshape Diagnostics Helps

Proteoshape Diagnostics Makes a Difference

How Proteoshape Diagnostics Helps

We develop highly sensitive tools for early detection of Alzheimer disease and Alzheimer disease related dementias before neuronal damage accumulates. 

Proteoshape Diagnostics Makes a Difference

Proteoshape Diagnostics Makes a Difference

Proteoshape Diagnostics Makes a Difference

We will offer fast and early detection of neurodegenerative disease markers prior to onset of Alzheimer disease.

Our Research and Development Pipeline

Diagnostics of Neurodegenerative Diseases

Diagnostics of Neurodegenerative Diseases

Diagnostics of Neurodegenerative Diseases

We develop and provide service for the early detection of Alzheimer disease and additional neurodegenerative diseases.

Cancer Conformational Biomarkers

Diagnostics of Neurodegenerative Diseases

Diagnostics of Neurodegenerative Diseases

We develop and validate conformational biomarkers that guide the selection of the best anticancer drug for therapeutic treatment.


Anticancer Drug Development

Diagnostics of Neurodegenerative Diseases

Anticancer Drug Development

We have exploratory stage drug candidates for the treatment of protein misfolding diseases and cancer.

Become an Investor in Proteoshape Diagnostics Corporation

LinkedIn
LinkedIn
LinkedIn
LinkedIn
LinkedIn
LinkedIn

Copyright © 2022 Proteoshape Diagnostics Corporation - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept